Logo-npj

Review

Administration of vadadustat for anemia of chronic kidney disease; an updated review
Sajad Ataei Azimi ORCID, Asaad Abass Fadhel Khalif, Ahmadreza Siyasari ORCID, Zahra Bazargani ORCID, Peyman Khajehnabi ORCID, Sara Ghaseminejad Kermani ORCID, Kamran Safa ORCID, Shirin Shamsghahfarokhi* ORCID
J Nephropharmacol. Corrected Proof, doi: 10.34172/npj.2025.12806 | Published on: 2025 Aug 17
Inpress FilePDF
Original

Potential of a palladium–Mexidol complex in normalization of liver tests as a dual organoprotective of hepato-renal function in a paracetamol-induced rat model
Fuad Yusir Mammadov ORCID, Shahzada Musa Polukhova ORCID, Zumrud Amirgulu Abaszade* ORCID, Kamil Sahib Alkishiev ORCID, Hijran Faramaz Khidirova ORCID, Maryam Rauf Abbasova ORCID, Aygun Vugar Kazimli ORCID
J Nephropharmacol. Corrected Proof, doi: 10.34172/npj.2025.12805 | Published on: 2025 Aug 09
Inpress FilePDF
Original

Investigation of CTLA-4 gene polymorphisms in a sample of Iraqi children with newly diagnosed type 1 diabetes mellitus
Ealaf Abbas Khudair ORCID, Arwa Mujahid Al-Shuwaikh* ORCID, Dawood Salman Abdoun
J Nephropharmacol. Corrected Proof, doi: 10.34172/npj.2025.12702 | Published on: 2025 Jul 26
Inpress FilePDF
Original

Investigating the therapeutic potential of esculetin in mitigating myocardial infarction-associated gut dysbiosis through targeted NLRP3 gene; an experimental animal study
Zahraa Jabbar Mujbel* ORCID, Gaith Ali Jasim ORCID, Huda Jaber Waheed ORCID
J Nephropharmacol. Corrected Proof, doi: 10.34172/npj.2025.12781 | Published on: 2025 Jul 14
Inpress FilePDF
Mini-Review

Psoriatic-nephropathy; an under-noticed disease
Ghadah Ali Al-Oudah* ORCID
J Nephropharmacol. Corrected Proof, doi: 10.34172/npj.2025.12752 | Published on: 2025 Jun 29
Inpress FilePDF